DIR Return Create A Forum - Home
---------------------------------------------------------
MS Speaks
HTML https://msspeaks.createaforum.com
---------------------------------------------------------
*****************************************************
DIR Return to: TYSABRI (natalizumab)
*****************************************************
#Post#: 996--------------------------------------------------
(Abst.) Asymptomatic PML during Tysabri therapy with treatment
DIR By: agate
Date: November 8, 2015, 12:30 am
---------------------------------------------------------
It's unsettling that a person can have asymptomatic PML. This
abstract describes such a case, in an MS patient taking Tysabri.
From PubMed, November 7, 2015:
--- Quote ---
> J Clin Neurosci. 2015 Nov 2. pii: S0967-5868(15)00517-2.
>
> Asymptomatic progressive multifocal leukoencephalopathy during
natalizumab therapy with treatment
>
> Fabis-Pedrini MJ1, Xu W2, Burton J1, Carroll WM1, Kermode AG3.
>
> Author information
>
> 1Centre for Neuromuscular and Neurological Disorders, Western
Australian Neuroscience Research Institute, The University of
Western Australia, Sir Charles Gairdner Hospital, 4th Floor, A
Block, QEII Medical Centre, Verdun Street, Nedlands, WA 6009,
Australia.
> 2Centre for Neuromuscular and Neurological Disorders, Western
Australian Neuroscience Research Institute, The University of
Western Australia, Sir Charles Gairdner Hospital, 4th Floor, A
Block, QEII Medical Centre, Verdun Street, Nedlands, WA 6009,
Australia; Department of Neurology, The Third Affiliated
Hospital of Sun Yat-sen University, Guangzhou, China.
> 3Centre for Neuromuscular and Neurological Disorders, Western
Australian Neuroscience Research Institute, The University of
Western Australia, Sir Charles Gairdner Hospital, 4th Floor, A
Block, QEII Medical Centre, Verdun Street, Nedlands, WA 6009,
Australia; Institute of Immunology and Infectious Diseases,
Murdoch University, Murdoch, WA 6150, Australia. Electronic
address: kermode@me.com.
>
>
> We report a case of asymptomatic progressive multifocal
leukoencephalopathy (PML) detected on regular MRI screening in a
40-year-old patient with subsequent benign course with 12-months
follow-up.
>
> The patient had a history of aggressive inflammatory multiple
sclerosis, prior mitoxantrone therapy, Stratify John Cunningham
Virus test positivity (Quest Diagnostics, Madison, NJ, USA), and
5 years of natalizumab monotherapy. The initial MRI detection of
PML was both atypical and subtle. Early diagnosis and
intervention, and pre-emptive treatment for immune
reconstitution inflammatory syndrome with high dose steroids, as
well as empirical mirtazapine and mefloquine, were associated
with a benign PML disease course and outcome.
--- End Quote ---
The abstract can be seen here
HTML http://www.ncbi.nlm.nih.gov/pubmed/26541323.
*****************************************************
Page 1 of 1